| PERIOD ENDING | 30-Sep-08 | 30-Sep-07 | | Total Revenue | 21,295 | 11,151 | | Cost of Revenue | 10,305 | 5,020 | | | Gross Profit | 10,990 | 6,131 | | | Operating Expenses | | Research Development | 619 |
-
| | Selling General and Administrative | 9,825 | 6,768 | | Non Recurring | 9,828 |
-
| | Others | 1,051 | 369 | | | | Total Operating Expenses | 21,323 |
-
| | | | Operating Income or Loss | (10,333) | (1,006) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 85 | 33 | | Earnings Before Interest And Taxes | (10,248) | (973) | | Interest Expense | 61 | 924 | | Income Before Tax | (10,309) | (1,897) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (10,309) | (1,897) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (10,309) | (1,897) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($10,309) | ($1,897) |
|
0.29% Nasdaq 
Income Statement
